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Modifications of Gait as Predictors of
Natural Osteoarthritis Progression in STR/Ort Mice
Blandine Poulet,1 Roberto de Souza,2 Chancie B. Knights,3 Clive Gentry,3 Alan M. Wilson,4
Stuart Bevan,3 Yu-Mei Chang,5 and Andrew A. Pitsillides5
Objective. Osteoarthritis (OA) is a common
chronic disease for which disease-modifying therapies
are not currently available. Studies to seek new targets
for slowing the progress of OA rely on mouse models,
but these do not allow for longitudinal monitoring of
disease development. This study was undertaken to
determine whether gait can be used to measure disease
severity in the STR/Ort mouse model of spontaneous
OA and whether gait changes are related to OA joint
pain.
Methods. Gait was monitored using a treadmill-
based video system. Correlations between OA severity
and gait at 3 treadmill speeds were assessed in STR/Ort
mice. Gait and pain behaviors of STR/Ort mice and
control CBA mice were analyzed longitudinally, with
monthly assessments.
Results. The best speed to identify paw area
changes associated with OA severity in STR/Ort mice
was found to be 17 cm  seconds1. Paw area was
modified with age in CBA and STR/Ort mice, but this
began earlier in STR/Ort mice and correlated with the
onset of OA at 20 weeks of age. In addition, task
noncompliance appeared at 20 weeks. Surprisingly,
STR/Ort mice did not show any signs of pain with OA
development, even when treated with the opioid antag-
onist naloxone, but did exhibit normal pain behaviors in
response to complete Freund’s adjuvant–induced ar-
thritis.
Conclusion. The present results identify an ani-
mal model in which OA severity and OA pain can be
studied in isolation from one another. The findings
suggest that paw area and treadmill noncompliance may
be useful tools to longitudinally monitor nonpainful OA
development in STR/Ort mice. This will help in provid-
ing a noninvasive means of assessing new therapies to
slow the progression of OA.
Osteoarthritis (OA), the most common chronic
joint disease (affecting25% of persons age60 years),
remains without effective disease-modifying therapy.
Animal models have been used to study OA, with mouse
studies currently central in providing the paradigms
aimed at identifying new treatment targets. Mouse mod-
els of spontaneous and mechanically induced OA each
have similarities to human disease (1–4). Beginning at
20 weeks of age, male STR/Ort mice develop a natural
OA (5,6) that engages mechanisms resembling those of
human OA, with loss of articular cartilage proteoglycan,
progressive articular cartilage degeneration (6), osteo-
phytogenesis, and subchondral bone thickening (1,7–9).
The usefulness of these mice for studying OA is, how-
ever, limited by their small joint size and by the paucity
of noninvasive tools for longitudinal monitoring of dis-
ease.
Methods for noninvasive monitoring of OA se-
verity would enhance the utility of STR/Ort mice for the
study of OA and enhance efforts to develop new thera-
pies. Specific gait modifications have been linked with
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OA severity and knee pain in humans (10–13), and ad-
vances in monitoring of pain-associated changes in mu-
rine OA would be highly advantageous. Indeed, recent
studies have demonstrated that measures of gait repre-
sent a simple and objective method for monitoring both
arthritis development and treatment response (14,15).
With a view toward extending these analyses to
mice with spontaneous OA, we have addressed whether
gait changes, which may reflect pain, can be used to
monitor OA progression in STR/Ort mice. To our
knowledge, few such in-depth studies focusing on gait
measurement in mice have been performed previously
(16). We used treadmill-based analyses to determine
whether biomechanical characteristics of gait in STR/
Ort mice are predictive of OA onset or progression and
whether these changes are related to OA joint pain. We
found that paw area was the best predictor of the
severity of spontaneous OA in STR/Ort mice. Surpris-
ingly, we also observed that STR/Ort mice with OA did
not exhibit significant pain behaviors and that treadmill
task noncompliance (refusal to run) was another poten-
tial noninvasive measure of advanced OA in this natu-
rally OA-prone strain. Our findings suggest that dis-
abling, likely structural, joint changes, as opposed to
pain, are responsible for modifications in gait seen
during OA development in these mice and that reduced
paw area and treadmill task noncompliance are the most
effective measures of OA onset and progression. They
also highlight the possible identification of the STR/Ort
mouse as a new animal model to enable study of
mechanisms involved in the development of severe OA
without the complicating factor of associated pain.
MATERIALS AND METHODS
Animals. Male CBA mice (Charles River) and STR/
Ort mice (bred at our institution) were kept in polypropylene
cages, subjected to 12-hour light/dark cycles at 21°C (2°C),
and fed standard RM1 maintenance diet (Special Diet Ser-
vices) ad libitum. All procedures were in compliance with the
Animals (Scientific Procedures) Act (1986) and were approved
by the local ethics committee.
CBA is a member of the parental stock from which
STR/Ort mice were originally derived (17,18), and age-
matched CBA mice were included as a non–OA-prone, healthy
joint aging control group. In study 1, 33 STR/Ort mice ages
18–56 weeks (encompassing all grades of OA) were used to
determine the optimum treadmill speed (13, 17, or 24 cm 
seconds1) to maximize gait differences at distinct degrees of
OA severity and for preliminary assessments prior to longitu-
dinal analyses; data on all animals were included regardless of
possible noncompliance with running at some speeds. Mice
were killed by cervical dislocation, and knees were fixed,
decalcified (Immunocal), and 6-m coronal wax sections cut.
Sections (120-m intervals) across each entire joint were
stained with toluidine blue, and OA severity was graded using
the Osteoarthritis Research Society International scoring sys-
tem (19). In study 2, 13 STR/Ort mice ages 20–25 weeks were
used to determine the frequency of task noncompliance at
treadmill speeds of 17 and 24 cm  seconds1. In study 3, 7
STR/Ort mice age 16 weeks were used to test the reproduc-
ibility of gait recordings on 10 separate occasions over 2 weeks.
In study 4, 22 STR/Ort mice and 20 CBA mice were used to
longitudinally analyze gait (assessed monthly) between the
ages of 8 weeks and 36 weeks. In study 5, 13 STR/Ort mice and
10 CBA mice were used to assess pain behaviors between the
ages of 16 weeks and 36 weeks.
Gait analysis. Gait was recorded using a DigiGait
imaging system (Mouse Specifics) (14). Briefly, mice ran on a
transparent flat treadmill at a specific speed, while a video
camera captured ventral images. Animals ran for a maximum
of 30 seconds for each measurement, with segments of 5
seconds (which corresponded to 10 consecutive strides) used
for analysis. No habituation procedures were used for these
studies at any time. DigiGait image analysis software automat-
ically defines each paw area, generates waveforms to describe
advance/retreat of each limb in consecutive strides, and iden-
tifies periods of time when each paw is in treadmill contact as
stance phase, and intervening periods as swing phase. Postural
and kinematic gait measurements are also calculated, including
stride time, stride length, and paw area. Brake and propel
times were defined as the times before and after maximal paw
area during the stance phase, and paw angle was represented
as the angle of the paw relative to the long axis (14). The
symmetry index is defined as the absolute value of the differ-
ence between contralateral hind limbs divided by their average.
After investigation of a range of speeds (study 1) and repro-
ducibility (study 2), treadmill speed for subsequent studies
(study 3) was set at 17 cm  seconds1.
Mouse treadmill task noncompliance (i.e., refusal to
undertake or complete the treadmill running task, which would
be observed as inability or unwillingness of a mouse to take
more than 2 consecutive strides) was also recorded. Noncom-
pliance, or “dropout,” was irreversible; reluctance of any
STR/Ort mouse to complete the task meant that this particular
mouse would not comply on any further occasions upon which
opportunity was afforded (i.e., a trial with noncompliance
would not be followed at any time in the future by a trial in
which compliance was achieved).
Measurement of pain-associated behavior. Pain behav-
iors (20) in the hind limbs of 16–36-week-old STR/Ort mice
(n  13) and CBA mice (n  10) (study 5) were assessed.
Briefly, mechanical allodynia was assessed by placing mice in a
Perspex chamber with a metal grid floor and the paw’s plantar
surface (left and right hind paws) touched for 6 seconds with
von Frey filaments in ascending order of force (0.04–1.4g). A
positive response was recorded if the paw was sharply with-
drawn or if flinching was observed upon filament removal.
Once a positive withdrawal response was established, the paw
was retested starting with the next descending von Frey
filament until no response occurred; the testing of responses to
von Frey filaments of ascending and descending force was then
repeated until a reproducible threshold force was determined.
The results were therefore based on at least 2 rounds of
measurements. The smallest force eliciting a response was
recorded as the paw withdrawal threshold (20,21). Mechanical
hyperalgesia (paw pressure) was assessed by applying increas-
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ing pressure stimulus on the hind paw’s dorsal surface using an
analgesymeter (no. 7200; Ugo Basile) and recording the de-
gree of pressure at which paw withdrawal was induced (22).
Cold sensitivity was assessed using a 10°C cold-plate (Ugo
Basile), with time until paw withdrawal recorded (23).
The assessment of audible vocalizations has been
found to be a valid method for determining knee hypersensi-
tivity. For example, in a study of a surgical model of OA in
C57BL/6 mice with the operator being blinded with regard to
the clinical status of the groups under study, the number of
audible vocalizations was found to be consistent with OA pain
behaviors such as mechanical hypersensitivity (paw pressure)
and cold sensitivity (20). In the present study the number of
audible vocalizations was recorded during 10 repeated com-
pressions of the knee between the operator’s thumb and
forefinger with moderate force. Tests on all animals was
performed by the same operator. As the strains in the current
study are readily identifiable by their skin coloration, blinding
of the operator was not possible.
To define relationships between pain and gait changes,
carprofen (5 mg/kg) was administered intraperitoneally for 3
consecutive days (24) and gait analyzed on the third day. To
define whether absence of expected pain behaviors was due to
masking effects of endogenous opioids and to reveal likely
maxima in pain-related behavior, naloxone hydrochloride (2.5
mg/kg; Sigma-Aldrich) or vehicle was administered intraperi-
toneally to randomly allocated mice. Behavioral readings were
recorded before and 60 minutes after this treatment. To test
whether STR/Ort mice developed abnormal sensitivities in a
known joint pain model, inflammatory knee arthritis was
induced in 40–43-week-old STR/Ort mice (n  3) by intra-
articular injection of Freund’s complete adjuvant (CFA; Fisher
Scientific) (10 l; 0.1% [weight/volume] in mineral oil) and
pain measures assessed 72 hours later.
Statistical analysis. Data are shown as the mean 
SEM. Groups of STR/Ort mice in study 1 were compared by
one-way analysis (ANOVA) followed by Fisher’s post hoc
analysis of least significant difference and Holm’s adjustment
for multiple testing. Results obtained in studies 3 and 5 were
analyzed by repeated-measures ANOVA followed by Tukey’s
post hoc comparison. Effects of naloxone (study 5) were
compared by unpaired t-test. For longitudinal studies of gait in
STR/Ort and CBA mice (study 4), principal components
analysis (PCA), a dimension reduction technique, was used to
summarize 41 correlated measurements into a few uncorre-
lated principal components across both strains. Heatmaps were
Table 1. Parameters of hind limb gait and symmetry index according to OA severity, in STR/Ort mice performing treadmill tasks at 3 speeds*
Treadmill speed, parameter
Hind limb gait measurement, average of
both limbs Symmetry index†
Low/low
severity
Low/high
severity
High/high
severity
Low/low
severity
Low/high
severity
High/high
severity
24 cm/second (n  3, 6, 8)‡
Swing, msec 91  4 72  5§ 87  3 0.02 0.01 0.09  0.03 0.04 0.01
Brake, msec 41 8 32 3 33  2 0.08 0.04 0.16  0.05 0.19  0.05
Propel, msec 130 5 122  10 125 6 0.01  0.01 0.06  0.01 0.04  0.02
Stance, msec 172 3 155  12 157 6 0.02  0.01 0.06  0.02 0.07  0.02
Stride, msec 263 6 227  17 245 8 0.01  0.00 0.07  0.02 0.04 0.01
Paw area, cm2 0.99  0.02 0.89  0.05 0.76  0.08 0.03 0.01 0.09  0.03 0.12  0.02
Paw angle, degrees 13.8 3.2 14.0  1.2 12.5  1.3 0.12 0.03 0.31  0.14 0.18  0.06
17 cm/second (n  4, 9, 9)‡
Swing, msec 95 6 85  4 86  4 0.09 0.03 0.05  0.02 0.07 0.03
Brake, msec 38 7 41 3 48  3 0.13 0.05 0.22  0.04 0.22  0.04
Propel, msec 126 34 172  13 161 6 0.08  0.04 0.09  0.03 0.06  0.02
Stance, msec 164 40 212  15 209 6 0.08  0.04 0.09  0.03 0.06 0.01
Stride, msec 258 41 297  17 295  9 0.08  0.03 0.07  0.02 0.04 0.01
Paw area, cm2 0.50  0.10¶ 0.82  0.05 0.71  0.04 0.08 0.04 0.13  0.04 0.12  0.04
Paw angle, degrees 10.7 4.5 11.7  1.6 12.9  2.2 0.19 0.07 0.25  0.09 0.18  0.05
13 cm/second (n  5, 9, 9)‡
Swing, msec 89 9 81  7 94  9 0.10 0.04 0.07  0.02 0.10 0.02
Brake, msec 50 9 47 5 50  5 0.19 0.04 0.25  0.03 0.19  0.04
Propel, msec 201 24 184  20 197 16 0.12  0.02 0.14  0.04 0.08  0.03
Stance, msec 251 30 231  23 247 16 0.07  0.02 0.11  0.04 0.08 0.02
Stride, msec 341 38 313  29 341  23 0.07  0.03 0.09  0.03 0.06 0.02
Paw area, cm2 0.84  0.12 0.84  0.07 0.93  0.04 0.09 0.03 0.11  0.02 0.16  0.03
Paw angle, degrees 12.8 1.3 10.2  2.0 13.0  5.1 0.36 0.16 0.39  0.12 0.25  0.06
* Osteoarthritis (OA) severity in paired hind limbs was retrospectively graded as low/low (both left and right limbs with an OA grade of 4),
high/high (both limbs with a grade of 5), or low/high (one limb with a grade of 5 and contralateral limb with a grade of 4). Values are the
mean  SEM.
† Defined as the absolute value of the difference between contralateral hind limbs divided by their average.
‡ Number of mice in the low/low, low/high, and high/high OA severity groups, respectively.
§ P  0.02 versus the low/low and high/high severity groups by one-way analysis of variance with Fisher’s least significant difference test for post hoc
comparison.
¶ P  0.007 versus the low/high and high/high severity groups by one-way analysis of variance with Fisher’s least significant difference analysis for
post hoc comparison; significance remained after Holm’s adjustment for multiple testing.
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used to depict contributions (loading) of original gait measure-
ments to principal components, and linear mixed-effects mod-
els were used to assess whether principal components differed
between strains, by age, and strain–age interaction. First-
degree autoregressive covariance structure was used to ac-
count for correlation in repeated measurements. Discriminant
analysis, a data classification technique, is a procedure that
uses information on several variables and predicts the group to
which a subject belongs based on those variables. Discriminant
analysis was used to determine the linear combinations of gait
measurements that best discriminate age at “dropout” from
the treadmill task for the STR/Ort mice (no dropout was
evident in the non–OA-prone CBA mice). Unpaired t-tests
and repeated-measures ANOVA were performed using
GraphPad Prism version 6. PCA, discriminant analysis, and
linear mixed-effects analysis were carried out using SPSS
version 20. P values less than 0.05 were considered significant.
RESULTS
Association of modified paw area and paw angle
with OA severity. Before longitudinal analyses were
conducted, OA severity in the joints of 18–56-week-old
STR/Ort mice (n  33) was graded after analysis of gait
at various treadmill speeds (13, 17, and 24 cm  sec-
onds1) (study 1). As expected, higher treadmill speeds
led to decreased brake, propel, stance, and stride times
and increased stride length. After allocation of mice to 1
of 3 groups based on OA severity (low/low [both left and
right limbs with a grade of 4], high/high [both limbs
with a grade of 5], or low/high [one limb with grade of
5 and the contralateral limb with a grade of 4]),
experiments using treadmill speeds of 17 cm  seconds1
revealed significant differences in paw area according to
OA severity and speeds of 24 cm  seconds1 revealed
significant differences in swing time according to OA
severity, whereas no significant difference in gait was
observed at speeds of 13 cm  seconds1 (Table 1). Due
to the high number of statistical tests performed on the
data shown in Table 1, Holm’s adjustment for multiple
testing was performed; after this adjustment, the only
parameter that remained significantly different between
Figure 1. Link between gait and task noncompliance (treadmill task dropout) in osteoarthritis-prone STR/Ort mice, demonstrated by discriminant
analysis. A, Heatmap representing the contribution (loading) of the 41 gait parameters to the first 7 discriminant scores (DS). This analysis
demonstrates that paw area contributed the most to discriminant score 1. LR  left rear limb; RR  right rear limb; LF  left front limb; RF 
right front limb. B, Scatterplot of the first 2 discriminant scores based on gait changes occurring in STR/Ort mice at each month immediately prior
to the time of dropout. Modifications in gait (represented in discriminant score 1) occurred in the last 2 months preceding dropout from the treadmill
task. Thus, group 1 (each animal marked with this number) represents the final gait measurements in the month before dropout, group 2 the
second-to-last measurements before dropout (i.e., values from mice 2 months prior to dropout) and so on, up to group 8. Centroids for each of these
groups are shown in red. The further apart the centroids, the more accurate the group classification. The last 2 records before dropout had lower
discriminant score 1 values compared to the rest of the records.
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the groups categorized by disease severity was paw area
at 17 cm  seconds1. The data, however, suggest that
higher treadmill speeds will provide better detection of
OA-related gait changes and that paw area is likely a
particularly sensitive parameter. In addition, the group-
ing of mice and stringent statistical analysis revealed no
significant asymmetries in gait at any of the speeds
tested (Table 1).
STR/Ort mice were more task-compliant at
treadmill speeds of 17 cm  seconds1 compared to
higher speeds. The number of STR/Ort mice (20–25
weeks-old; n  13) that dropped out increased from 2 at
speeds of 17 cm  seconds1 to 8 at 24 cm  seconds1
(study 2). Given this relative noncompliance at faster
speeds and the gait changes associated with OA severity
at 17 cm  seconds1, further studies were performed at
17 cm  seconds1. The validity of longitudinal gait
examinations depends both on reproducibility and on
the possible impact of each treadmill task on subsequent
gait. We therefore measured gait at treadmill speeds of
17 cm  seconds1 on 10 separate occasions over 2 weeks
in 16-week-old STR/Ort mice (n  7) and found that
none of the parameters showed any significant changes
(study 3; data not shown).
Gait analysis reveals paw area as the main
parameter associated with OA in aging STR/Ort mice.
Monthly treadmill task analysis in CBA and STR/Ort
mice from age 8 weeks to age 36 weeks (study 4)
demonstrated that CBA mice showed full compliance,
whereas only 3 of 22 STR/Ort mice (14%) completed the
task throughout the study period. Timing of the first
dropout by STR/Ort mice coincided with OA onset at 20
weeks (5), suggesting a possible link with OA develop-
ment. Discriminant analysis revealed that the gait of
STR/Ort mice during the 2 months immediately prior to
dropout deviated significantly from gait at earlier time
Figure 2. Longitudinal variation in the first principal component analysis (PCA1) and one of its individual components (stride time) is not
associated with aging in CBA or STR/Ort mice. A, Heatmap representing the contribution (loading) of the 41 gait parameters to the first 6 principal
components (PCA1–PCA6) across ages in CBA and STR/Ort mice. This analysis demonstrates that stride, swing, stance, and propel time and stride
frequency contributed the most to PCA1 and that paw area contributed the most to PCA2. B, Changes in PCA1 in CBA mice and STR/Ort mice
between 8 and 36 weeks of age. Significant differences were noted between strains, but differences between time points were not observed. Data
are shown as box plots. Each box represents the 25th to 75th percentiles. Lines inside the boxes represent the median. Dashed lines outside the boxes
represent the 10th and the 90th percentiles. Dots represent individual mice. Circles indicate outliers. C, Stride time (mean of the left limbs and right
limbs of each animal) in CBA and STR/Ort mice. Stride times did not change significantly with aging, but were higher in STR/Ort mice than in CBA
mice (P  0.05) at all time points beginning at 8 weeks. D, Symmetry index for stride time in CBA and STR/Ort mice. Stride times did not change
significantly with aging and did not differ between strains. Values in C and D are the mean  SEM. For CBA mice, n  20 at all time points; for
STR/Ort mice, n  22 at weeks 8, 12, and 16, n  21 at week 20, n  17 at week 24, n  14 at week 28, n  13 at week 32, and n  3 at week 36.
See Figure 1 for other definitions.
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points (discriminant score 1; mainly included paw area)
(P  0.0001) (Figure 1). Comparison of OA severity in
the STR/Ort mice exhibiting early dropout versus those
exhibiting late dropout (20–24 weeks versus 32–36
weeks) showed that age at dropout did not correlate with
the OA grade at the end of the study (36 weeks).
PCA to assess whether gait changes in STR/Ort
and CBA mice were associated with age showed that the
first PC (PCA1) captured 39% of the variation in gait in
both CBA and STR/Ort mice, but failed to reveal any
age-related trend in gait (Figure 2B). PCA1 correlated
most with stride, swing, stance, and propel times, stride
length, and stride frequency (Figure 2A). These para-
meters were generally higher in STR/Ort mice compared
to CBA mice (except for stride frequency, for which the
opposite was the case), but did not change significantly
with age. In addition, the symmetry index did not reveal
any significant gait asymmetries with age in either strain
of mice.
The second PC (PCA2) captured 11% of varia-
tion, and revealed significant age-related patterns in
both strains (Figure 3A). In CBA mice, PCA2 remained
stable until age 28 weeks and decreased significantly at
32–36 weeks. In contrast, in STR/Ort mice, PCA2
showed a marked decrease earlier, i.e., at 20 weeks of
age, coinciding with dropout and with histologically
Figure 3. Longitudinal variation in the second principal component analysis (PCA2) and its individual component (paw area) reveals changes with
aging in CBA and STR/Ort mice. A, Changes in PCA2 in CBA mice and STR/Ort mice between 8 and 36 weeks of age. Significant differences were
noted between strains and over time. Data are shown as box plots. Each box represents the 25th to 75th percentiles. Lines inside the boxes represent
the median. Dashed lines outside the boxes represent the 10th and the 90th percentiles. Dots represent individual mice. Circles indicate outliers.
B, Paw area (mean of the left limbs and right limbs of each animal) in CBA and STR/Ort mice. In CBA mice paw area increased between 16 and
20 weeks of age and decreased from 28 weeks, whereas in STR/Ort mice paw area decreased from 20 weeks of age.   statistically significant
difference from 20-week value in CBA mice (P  0.000 at 8 weeks, 12 weeks, 16 weeks, 32 weeks, and 36 weeks); $  statistically significant
difference from 20-week value in STR/Ort mice (P  0.001 at 8 weeks, P  0.003 at 12 weeks, P  0.000 at 24 weeks, 28 weeks, and 32 weeks, and
P  0.017 at 36 weeks). C, Symmetry index for paw area in CBA and STR/Ort mice. In STR/Ort mice, the symmetry index was similar between 8
and 24 weeks of age and showed significant increases in asymmetry from 28 weeks of age, whereas CBA mice exhibited diminished asymmetry
between 20 and 28 weeks of age.  statistically significant difference from 20-week value in CBA mice (P 0.014 at 8 weeks, P 0.008 at 16 weeks,
P  0.016 at 32 weeks, and P  0.000 at 36 weeks); $  statistically significant difference from 20-week value in STR/Ort mice (P  0.000 at 28
weeks, P  0.001 at 32 weeks, and P  0.019 at 36 weeks). Values in B and C are the mean  SEM. For CBA mice, n  20 at all time points; for
STR/Ort mice, n  22 at weeks 8, 12, and 16, n  21 at week 20, n  17 at week 24, n  14 at week 28, n  13 at week 32, and n  3 at week 36.
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evident OA (5). Moreover, PCA2 patterns differed
significantly between STR/Ort and CBA mice (P 
0.0001), indicating that PCA2 gait measures might cor-
relate with OA progression. Paw area had the highest
loading for PCA2 (Figure 1A), showed similar aging-
related patterns in both strains of mice, and decreased at
28 weeks in CBA mice and 20 weeks in STR/Ort mice
(Figure 3B). The symmetry index for paw area showed
variation with age in CBA mice, with higher asymmetry
compared to STR/Ort mice. The pattern of change over
time in STR/Ort mice demonstrated increased asymme-
try in paw area only from 28 weeks of age, when OA was
progressing (Figure 3C).
Gait changes in osteoarthritic STR/Ort mice are
not due to pain. To determine whether gait differences
could be attributed to OA pain, gait was monitored in
34-week-old STR/Ort mice that had been provided with
pain relief by treatment with carprofen for 3 days. This
palliative treatment (24) did not modify any gait mea-
surements or treadmill noncompliance, suggesting that
gait changes in the STR/Ort mice were not due to pain.
To examine whether OA development in these mice was
associated with pain, sensitivity measures were obtained
in mice between 16 and 36 weeks of age (study 5), by
which age STR/Ort mice normally develop significant
OA pathology. In these analyses STR/Ort mice did not
display any significant changes in response to paw
pressure, cold sensitivity, mechanical allodynia (von
Frey filaments), or pain-related vocalizations, with all
results similar to those obtained in CBA mice (Figure 4).
To assess whether OA-related pain may be inhibited by
naturally occurring opioids in STR/Ort mice (20,25),
naloxone was administered. This treatment did not
result in modification of any pain sensitivity measures in
STR/Ort mice (Table 2).
Effects of CFA-induced joint inflammation were
also examined to determine if absence of pain behaviors
in STR/Ort mice was due to a general insensitivity.
Three 40–43-week-old STR/Ort mice injected with CFA
developed the expected range of pain-related behaviors,
with significant increases in sensitivity to mechanical
stimulation (from a mean  SEM of 0.6  0g to 0.24 
Figure 4. Pain behavior in STR/Ort and CBA mice does not show significant variation with age. Paw pressure (A), cold sensitivity (B), mechanical
allodynia (von Frey filaments) (C), and number of vocalizations following knee compression (D) were each measured once a month in the left and
right hind limbs of CBA and STR/Ort mice, from 16 weeks to 36 weeks of age. No significant changes with time were identified in either strain. (In
contrast, typical values for hypersensitivity in a study of surgically induced osteoarthritis in mice [20] were as follows: paw pressure 60–70g, cold
sensitivity 5–7 seconds, mechanical allodynia [von Frey filaments] 0.1–0.2g, and vocalizations 2.5–3.) Values are the mean  SEM.
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0.08g on von Frey filament testing and 155.00  5.77g to
96.67  3.33g on paw pressure testing), knee compres-
sion (from 0 0 vocalizations to 1 0.58 vocalizations),
and cold (from 23.30  3.37 seconds to 15.93  1.94
seconds). These data indicate that the absence of pain
behaviors in STR/Ort mice is likely not due to general
pain insensitivity and that gait changes occurring con-
comitantly with OA development in STR/Ort mice may
not be attributable to joint pain.
DISCUSSION
In this study we used video-based analyses to
identify gait changes in mice with naturally occurring
OA. We discovered links between specific gait modifi-
cations and OA severity, with paw area identified as
being potentially predictive. By examining pain-
associated behaviors, we also demonstrated that gait
changes in STR/Ort mice with OA are not accompanied
by measurable joint pain, indicating that hind limb paw
area measurement may be a useful, noninvasive moni-
toring tool that likely reflects structural, rather than
pain-related, changes in the joint. In addition, we found
that treadmill task noncompliance may serve as an
indicator of OA in these mice.
STR/Ort mice have predictable disease develop-
ment, with initial articular cartilage lesions occurring at
age 18–20 weeks (6) and progression to severe OA by 12
months (5). These mice develop characteristics resem-
bling those seen in human OA, including osteophytes,
subchondral bone sclerosis, and synovial hyperplasia
(1,7,9). CBA mice were used as controls for 2 reasons:
they are the closest commercially available genetic rela-
tive (used in initial cross to generate STR/Ort mice
[17,18]), and are very resistant to age-related spontane-
ous OA (5). Inclusion of CBA mice (as in study 4) allows
the confounding effects of aging to be limited.
Gait analysis has been attempted in only one
previously reported study of STR/Ort mice (26). Use of
ink pawprints revealed reduced variance in gait in
aspartame-fed mice in which histologically defined OA
was delayed. The data presented herein cannot be
compared with these findings; however, we have noted
increased variability in swing time in STR/Ort mice
compared to CBA mice (Poulet B, et al: unpublished
observations). Inherent strain-related differences were
centered around stride and stance, as well as around
propel and brake times, which are components of stance
times. Stride frequency and length and swing time, a
component of stride, were significantly different be-
tween strains at all ages, with STR/Ort showing larger
steps and longer components of stride than CBA mice.
Differences in body dimension in STR/Ort mice, such as
Table 2. Pain behavior in CBA and STR/Ort mice after treatment with the opioid antagonist naloxone*
CBA mice STR/Ort mice
Left hind limb Right hind limb Left hind limb Right hind limb
Paw pressure (paw withdrawal threshold), g
Predose (vehicle) 147 2 148  1 146 3 146 3
1 hour posttreatment vehicle) 143 5 143  5 145 3 147 2
Predose (naloxone) 144 2 145  3 147 1 149 1
1 hour posttreatment (naloxone) 146 3 146  3 137 3 140 2
Cold sensitivity (paw withdrawal time), seconds
Predose (vehicle) 19 1 19  1 21 3 22 3
1 hour posttreatment (vehicle) 19  1 20  1 21 2 21 2
Predose (naloxone) 18 2 18  2 21 2 22 2
1 hour posttreatment (naloxone) 20  2 20 2 19 2 20 3
Vocalizations, number
Predose (vehicle) 0 0 0 0 0 0 0 0
1 hour posttreatment (vehicle) 0  0 0 0 0 0 0 0
Predose (naloxone) 0 0 0.2  0.2 0  0 0 0
1 hour posttreatment (naloxone) 0.6 0.2 0 0 0 0 0 0
Mechanical allodynia (paw withdrawal threshold), g
Predose (vehicle) 0.8 0.1 0.9 0.1 0.8 0.1 0.8 0.1
1 hour posttreatment (vehicle) 0.8  0.1 0.8 0.1 0.7 0.1 0.9 0.1
Predose (naloxone) 0.9  0.1 0.9 0.1 0.7 0.1 0.8 0.1
1 hour posttreatment (naloxone) 0.8 0.1 0.8 0.1 0.7 0.1 0.8 0.1
* Paw pressure, cold sensitivity, mechanical allodynia (von Frey filaments), and number of vocalizations following knee compression were measured
before and 1 hour after intraperitoneal treatment with either control vehicle (n  10 CBA mice and 13 STR/Ort mice) or naloxone (n  10 CBA
mice and 13 STR/Ort mice). Analysis by unpaired t-test revealed that no significant changes were induced by the treatments in mice of either strain.
Values are the mean  SEM.
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weight and tibia length (data not shown), may be a factor
in inherent gait differences that lead to OA in these
mice.
Gait has previously been analyzed in models of
OA and inflammatory arthritis. Analysis of type IX
collagen–deficient mice, which develop OA spontane-
ously, revealed reduced stride length and increased
stance times compared to wild-type mice (27). Induction
of OA in transforming growth factor 1–injected mice
by treadmill running also led to increased stance times
and decreased swing time (15). Paw area was decreased
in rodents with carrageenan-induced rheumatoid arthri-
tis (28), but was increased after development of swelling
and inflammation in collagen-induced arthritis (29).
Contralateral limbs were not evaluated in either of those
studies. It is evident that decreased paw area suggests
greater weight focus to a smaller foot area, consistent
with the protection of specific joint locations from
weight bearing.
We found that paw area was correlated with OA
severity in STR/Ort mice, with a statistically significant
correlation observed only in comparisons between mice
with severe OA (grades 5–6) and mice with mild OA
(grades 0–4). In these mice, OA severity was linked
closely with modified paw area, suggesting a strong
association between gait impairment and disease sever-
ity. Longitudinal analysis, however, showed early de-
creases in paw area. These decreases may have multiple
origins, including the following: 1) less weight being
passed through that limb and more through the con-
tralateral, presumably less painful, limb might result in
decreased paw splaying; 2) muscles in a painful (or
osteoarthritic) limb may be contracting in a manner that
reduces pain, pulling the paw together (digital flexors) to
reduce paw area; or 3) joint angles may be changed to
deliver a more upright limb, reducing joint moments
and, hence, muscle forces.
Stratifying individual limb kinematics by OA
scores in individual limbs may provide better insight into
OA-dependent kinematic changes. Such stratification
would, however, be biased to only the OA-affected limb.
Our use of an unbiased approach, also examining gait in
both limbs, allows for consideration of any changes in
the contralateral limb. This is relevant in this OA model,
in which disease can affect left and right limbs indepen-
dently with age, unlike other models of acute arthritis
pain (29), in which the diseased or affected limb is
known. We used a symmetry index as a way of measuring
gait asymmetries in hind limbs, revealing asymmetries in
paw area with aging in both osteoarthritic STR/Ort and
control CBA mice. Further studies are under way to
identify asymmetries between all 4 limbs in more detail
and to investigate their associations with OA severity.
Gait changes in models of chronic inflammation
are associated mainly with increased pain sensitivity
(14,28,29). This contrasts with the present findings of
age-related gait changes, not associated with pain-
related behaviors, in CBA and STR/Ort mice. Our
results suggest that age-related modifications in gait are
instead due to structural changes. Similar conclusions
have been drawn from studies of human OA (30–33),
with only comparatively few studies having been con-
ducted in murine species (16). Healthy joint aging is
known to involve tendon stiffening (34), which may
modify gait by restricting joint movement and full heel–
toe strike. Decreased paw area in STR/Ort mice coin-
cides with OA onset at age 20 weeks, and later articular
changes, including osteophytes (8), ligament weakness,
and chondro-osseous changes (5,35,36), may in turn
contribute to gait modification in these mice.
As the etiology of OA in this model remains to be
defined, there are factors that may confound interpre-
tation of our data, including soft tissue calcification,
patellar subluxation, ankle deformity, and obesity (37–
39). Similar caveats apply to the possibility that differ-
ences in limb size and weight gain trajectories in CBA
and STR/Ort mice may affect gait. It is possible, there-
fore, that the gait patterns we have monitored may not
reflect functional biomechanical changes that occur dur-
ing OA development, and this remains a significant
limitation of our study. The changes in gait may reflect
normal aging processes, a consequence of OA-
dependent neuromuscular change, or some as-yet-
unidentified modification in these mice (40,41). Our
study revealed that CBA mice readily complied with
treadmill running tasks at all ages, whereas STR/Ort
mouse dropout coincided temporally with histologically
detectable OA at age 20 weeks. We propose that drop-
out counts may provide a noninvasive measure of OA in
appropriately sized STR/Ort mouse groups. We did not
ascertain whether dropout is linked to a specific OA
feature, and future work will be undertaken to define
whether a specific physical impairment underlies this
phenomenon.
A significant and somewhat surprising result of
this study was the lack of pain sensitivity in osteoarthritic
STR/Ort mice. Responses to mechanical allodynia or
paw pressure, cold sensitivity, and joint compression–
related vocalization did not differ between these mice
and controls, and no modification in their gait was
observed after carprofen or opioid antagonist treatment.
These intriguing observations should be placed into
context with OA in humans, with pain not always
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experienced despite radiographic diagnosis (42–44). In-
deed, 60% of patients with OA diagnosed by a physi-
cian or confirmed radiographically failed to report knee
pain (43). This is likely to contribute to late diagnosis
and limitation of protective measures, and to exacerbate
known propensities toward OA in the contralateral limb.
Our data identify STR/Ort mice as a model of asymp-
tomatic OA and highlight the novel and exciting putative
utility of this model in identifying markers and processes
of joint degeneration without the complicating factor of
pain.
Long-term changes in gait may not be reversible
with short-term analgesia. Indeed, it is possible that
initial gait adaptation could be due to pain, but repeat-
ing this adaptation and avoiding pain during locomotion
may lead the musculoskeletal system to remodel over
time and program the abnormality into the gait se-
quence. The subsequent blocking of pain mechanisms
long after a gait modification has been established, as
tested with carprofen treatment in this study, may not
immediately modify the gait abnormality. Even in the
clinical setting, physical therapy or training may be
needed to reset the gait sequence and this is, in part, a
large motivation for physical therapy and exercise as a
treatment for OA. In addition, although no pain in
STR/Ort mice before or after the onset of OA was
detected using our methods, we can only suggest that
abnormalities in gait in these mice are not due to pain.
In addition, the reaction to pain can be complex and not
always intuitive (42,43) and does not always result in a
simple unloading of the affected body part. Direct
measurement of limb forces would help in exploring
these effects but such measurements, while common in
studies of larger animals (45), are challenging in animals
the size of a transgenic mouse.
Noninvasive murine gait measurement is techni-
cally challenging, with most studies using “footprint”
analysis (26). DigiGait involves video-recording and
benefits from automatic computing with minimal oper-
ator error, and from treadmill use with adjustable run-
ning speed that allows adjustments that can reveal gait
changes only detectable at specific speeds. Another
advantage is the high reproducibility of data recorded
upon repeat treadmill testing in the same mouse. Mea-
surement of brake and propel times, however, has not
been validated by force plate analysis, and thus these
data must be considered with caution.
The present findings indicate that noninvasive
changes in gait, unrelated to classic joint pain measures,
are useful in monitoring OA in STR/Ort mice. Our study
identifies modifications in paw area as being a particu-
larly useful parameter and treadmill noncompliance as a
potential means of monitoring development of nonpain-
ful, structural OA in these mice. We speculate that this
will facilitate future longitudinal noninvasive assess-
ments of new therapies to help slow the progression of
OA. It may also facilitate reduction and refinement of
animal use by partially replacing histologic methods for
OA grading.
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